Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sigilon

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Mar 25, 2021 2:20pm

167 Views

Post# 32876666

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Sigilon

Yes they are all vying for the same thing but you can be sure GORE is never going to buy out ViaCyte.

AgeX Therapeutics is collaborating with Sernova using their UniverCyte gene technology to generate immune-protected universal therapeutic cells. When it's mutually beneficial companies will disclose their names. When it's not, they will remain anonymous.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment